Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (71-80 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|June 1, 1997
[The mechanism of action of hypolipidemic drugs]A J Scheen
Revue Medicale De Liege|June 10, 2015
[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors]A J Scheen
Revue Medicale Suisse|September 16, 2006
[Controversies in judgment criteria of cardiovascular prevention studies]A J Scheen
Human Reproduction (Oxford, England)|December 24, 1997
Perspective in the treatment of insulin resistanceA J Scheen
Revue Medicale De Liege|June 9, 2004
[Ezetimibe (Ezetrol)]A J Scheen
Revue Medicale De Liege|March 24, 2004
[Drug of the month. Rosuvastatin (Crestor)]A J Scheen
Revue Medicale De Liege|April 29, 2004
[Medication of the month. Insulin glargine (Lantus)]A J Scheen
Annales D'Endocrinologie|May 4, 2004
Pathophysiology of insulin secretionA J Scheen
Diabete & Metabolisme|May 1, 1989
[Pharmacokinetics of insulin administered subcutaneously. Application to treatment by portable pump (1)]A J Scheen
Revue Medicale De Liege|September 18, 2015
[New Myriad of summer-time clinical cases]A J Scheen
Pageof 79

Showing results (71-80 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|June 1, 1997
[The mechanism of action of hypolipidemic drugs]A J Scheen
Revue Medicale De Liege|June 10, 2015
[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors]A J Scheen
Revue Medicale Suisse|September 16, 2006
[Controversies in judgment criteria of cardiovascular prevention studies]A J Scheen
Human Reproduction (Oxford, England)|December 24, 1997
Perspective in the treatment of insulin resistanceA J Scheen
Revue Medicale De Liege|June 9, 2004
[Ezetimibe (Ezetrol)]A J Scheen
Revue Medicale De Liege|March 24, 2004
[Drug of the month. Rosuvastatin (Crestor)]A J Scheen
Revue Medicale De Liege|April 29, 2004
[Medication of the month. Insulin glargine (Lantus)]A J Scheen
Annales D'Endocrinologie|May 4, 2004
Pathophysiology of insulin secretionA J Scheen
Diabete & Metabolisme|May 1, 1989
[Pharmacokinetics of insulin administered subcutaneously. Application to treatment by portable pump (1)]A J Scheen
Revue Medicale De Liege|September 18, 2015
[New Myriad of summer-time clinical cases]A J Scheen
Pageof 79